554 related articles for article (PubMed ID: 32765502)
21. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition.
Garbers C; Aparicio-Siegmund S; Rose-John S
Curr Opin Immunol; 2015 Jun; 34():75-82. PubMed ID: 25749511
[TBL] [Abstract][Full Text] [Related]
22. Plasticity and cross-talk of interleukin 6-type cytokines.
Garbers C; Hermanns HM; Schaper F; Müller-Newen G; Grötzinger J; Rose-John S; Scheller J
Cytokine Growth Factor Rev; 2012 Jun; 23(3):85-97. PubMed ID: 22595692
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis.
Janssens K; Slaets H; Hellings N
Ann N Y Acad Sci; 2015 Sep; 1351():52-60. PubMed ID: 26100315
[TBL] [Abstract][Full Text] [Related]
24. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
[TBL] [Abstract][Full Text] [Related]
25. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
Hirano T; Matsuda T; Nakajima K
Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
[TBL] [Abstract][Full Text] [Related]
26. Identification of three distinct receptor binding sites of murine interleukin-11.
Barton VA; Hudson KR; Heath JK
J Biol Chem; 1999 Feb; 274(9):5755-61. PubMed ID: 10026196
[TBL] [Abstract][Full Text] [Related]
27. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1.
Benigni F; Fantuzzi G; Sacco S; Sironi M; Pozzi P; Dinarello CA; Sipe JD; Poli V; Cappelletti M; Paonessa G; Pennica D; Panayotatos N; Ghezzi P
Blood; 1996 Mar; 87(5):1851-4. PubMed ID: 8634432
[TBL] [Abstract][Full Text] [Related]
28. Activating mutations of the gp130/JAK/STAT pathway in human diseases.
Lokau J; Garbers C
Adv Protein Chem Struct Biol; 2019; 116():283-309. PubMed ID: 31036294
[TBL] [Abstract][Full Text] [Related]
29. Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during Inflammation.
Lokau J; Agthe M; Garbers C
Mediators Inflamm; 2016; 2016():1785021. PubMed ID: 27493449
[TBL] [Abstract][Full Text] [Related]
30. Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling.
Kurdi M; Booz GW
J Cardiovasc Pharmacol; 2007 Aug; 50(2):126-41. PubMed ID: 17703129
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-6: Biology, signaling and strategies of blockade.
Schaper F; Rose-John S
Cytokine Growth Factor Rev; 2015 Oct; 26(5):475-87. PubMed ID: 26189695
[TBL] [Abstract][Full Text] [Related]
32. IL-6 cytokine family and signal transduction: a model of the cytokine system.
Hibi M; Nakajima K; Hirano T
J Mol Med (Berl); 1996 Jan; 74(1):1-12. PubMed ID: 8834766
[TBL] [Abstract][Full Text] [Related]
33. Modular organization of Interleukin-6 and Interleukin-11 α-receptors.
Nitz R; Lokau J; Aparicio-Siegmund S; Scheller J; Garbers C
Biochimie; 2015 Dec; 119():175-82. PubMed ID: 26551279
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
[TBL] [Abstract][Full Text] [Related]
35. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer.
Jones SA; Jenkins BJ
Nat Rev Immunol; 2018 Dec; 18(12):773-789. PubMed ID: 30254251
[TBL] [Abstract][Full Text] [Related]
36. Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases.
Fujio Y; Maeda M; Mohri T; Obana M; Iwakura T; Hayama A; Yamashita T; Nakayama H; Azuma J
J Pharmacol Sci; 2011; 117(4):213-22. PubMed ID: 22056652
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6.
Boulanger MJ; Chow DC; Brevnova E; Martick M; Sandford G; Nicholas J; Garcia KC
J Mol Biol; 2004 Jan; 335(2):641-54. PubMed ID: 14672670
[TBL] [Abstract][Full Text] [Related]
38. gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities.
Nakashima K; Taga T
Semin Hematol; 1998 Jul; 35(3):210-21. PubMed ID: 9685167
[TBL] [Abstract][Full Text] [Related]
39. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression.
Jackson CB; Judd LM; Menheniott TR; Kronborg I; Dow C; Yeomans ND; Boussioutas A; Robb L; Giraud AS
J Pathol; 2007 Oct; 213(2):140-51. PubMed ID: 17724739
[TBL] [Abstract][Full Text] [Related]
40. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.
Fischer P; Hilfiker-Kleiner D
Basic Res Cardiol; 2007 Jul; 102(4):279-97. PubMed ID: 17530315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
